Company: ChromaDex Corporation
Ticker: Nasdaq: CDXC
Sector: Consumer
Investor Contact: Ben Shamsian

ChromaDex Corporation Investor Resources

Videos

ChromaDex Corp. (CDXC) Company Webcast

ChromaDex Corp. (CDXC) Company Webcast

This company webcast features ChromaDex Corp. (Nasdaq: CDXC). ChromaDex is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging. This company webcast was recorded during the Lytham Partners 2025 Investor...

read more
ChromaDex Corporation (CDXC) Fireside Chat

ChromaDex Corporation (CDXC) Fireside Chat

During this fireside chat Ben Shamsian, Vice President, Lytham Partners and Sean McGowan, Roth Capital Partners, chat with Rob Fried, Chief Executive Officer of ChromaDex Corporation. ChromaDex (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide...

read more
Skip to content